To improve the efficacy of adoptive cell therapy for patients with cancer, the cytokine status of the CD8+ T cell expansion was examined rather than the quality required for the maintenance and generation of long-lived memory CD8+ T cells. The gene discussed is CD8A; the disease is cancer.